Gene · 7402
Papers3,966
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 3,966
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Histone Deacetylases: Molecular Mechanisms and Therapeutic Implications for Muscular Dystrophies. | Int J Mol Sci | 2023 | 36901738 | PubTator, text mining | PubMed |
| Humic substances from composted fennel residues control the inflammation induced by Helicobacter pylori infection in AGS cells. | PLoS One | 2023 | 36893132 | PubTator, text mining | PubMed |
| miR-34a/DRP-1-mediated mitophagy participated in cisplatin-induced ototoxicity via increasing oxidative stress. | BMC Pharmacol Toxicol | 2023 | 36882858 | PubTator, text mining | PubMed |
| Exercise activates Sirt1-mediated Drp1 acetylation and inhibits hepatocyte apoptosis to improve nonalcoholic fatty liver disease. | Lipids Health Dis | 2023 | 36882837 | PubTator, text mining | PubMed |
| Muscle pathology of antisynthetase syndrome according to antibody subtypes. | Brain Pathol | 2023 | 36882048 | PubTator, text mining | PubMed |
| Chemistry, structure and function of approved oligonucleotide therapeutics. | Nucleic Acids Res | 2023 | 36881759 | PubTator, text mining | PubMed |
| Transferred mitochondria accumulate reactive oxygen species, promoting proliferation. | Elife | 2023 | 36876914 | PubTator, text mining | PubMed |
| Micro-dystrophin gene therapy demonstrates long-term cardiac efficacy in a severe Duchenne muscular dystrophy model. | Mol Ther Methods Clin Dev | 2023 | 36874243 | PubTator, text mining | PubMed |
| Organocatalytic asymmetric synthesis of P-stereogenic molecules. | Front Chem | 2023 | 36874062 | PubTator, text mining | PubMed |
| Compartment specific mitochondrial dysfunction in Drosophila knock-in model of ALS reversed by altered gene expression of OXPHOS subunits and pro-fission factor Drp1. | Mol Cell Neurosci | 2023 | 36868541 | PubTator, text mining | PubMed |
| Editorial: Mitochondrial therapy in neurodegeneration. | Front Pharmacol | 2023 | 36860297 | PubTator, text mining | PubMed |
| Mitochondrial dynamics in vascular remodeling and target-organ damage. | Front Cardiovasc Med | 2023 | 36860274 | PubTator, text mining | PubMed |
| CCBE1 promotes mitochondrial fusion by inhibiting the TGFβ-DRP1 axis to prevent the progression of hepatocellular carcinoma. | Matrix Biol | 2023 | 36849082 | PubTator, text mining | PubMed |
| White matter injury, cholesterol dysmetabolism, and APP/Abeta dysmetabolism interact to produce Alzheimer's disease (AD) neuropathology: A hypothesis and review. | Front Aging Neurosci | 2023 | 36845656 | PubTator, text mining | PubMed |
| miR-9a-5p Protects Ischemic Stroke by Regulating Oxidative Stress and Mitochondrial Autophagy. | Dis Markers | 2023 | 36845011 | PubTator, text mining | PubMed |
| Effects of Trimetazidine on Right Ventricular Function and Ventricular Remodeling in Patients with Pulmonary Artery Hypertension: A Randomised Controlled Trial. | J Clin Med | 2023 | 36836104 | PubTator, text mining | PubMed |
| The APC/C Activator Cdh1p Plays a Role in Mitochondrial Metabolic Remodelling in Yeast. | Int J Mol Sci | 2023 | 36835555 | PubTator, text mining | PubMed |
| Melatonin-Assisted Cisplatin Suppresses Urinary Bladder Cancer Cell Proliferation and Growth through Inhibiting PrPC-Regulated Cell Stress and Cell Proliferation Signaling. | Int J Mol Sci | 2023 | 36834767 | PubTator, text mining | PubMed |
| Ultra-Rare Variants Identify Biological Pathways and Candidate Genes in the Pathobiology of Non-Syndromic Cleft Palate Only. | Biomolecules | 2023 | 36830605 | PubTator, text mining | PubMed |
| The Anti-Aging Hormone Klotho Promotes Retinal Pigment Epithelium Cell Viability and Metabolism by Activating the AMPK/PGC-1α Pathway. | Antioxidants (Basel) | 2023 | 36829944 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7402/papers?page=46